Evidence map›Paper›PMID 33917523›Full record

ArticleJournal of clinical medicine2021

Clinical Characteristics and Degree of Glycemic and Cardiovascular Risk Factor Control in Patients with Type 1 Diabetes in Catalonia (Spain).

Gabriel Gimenez-Perez, Josep Franch-Nadal, Emilio Ortega, Manel Mata-Cases, Albert Goday, Jordi Real, Angel Rodriguez, Bogdan Vlacho, Dídac Mauricio

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Physical activity patterns in type 1 diabetes in Spain: The SED1 study.BMC sports science, medicine & rehabilitation · 2023
    Article
  4. Article
  5. The Bittersweet Beat: Diabetes Complications.Journal of clinical medicine · 2023
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 1 country.

Gabriel Gimenez-PerezEndocrinology Unit, Department of Medicine, Hospital General de Granollers, 08402 Granollers, Spain.ORCID 0000-0002-8541-766X
Josep Franch-NadalDAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
Emilio OrtegaDepartment of Endocrinology & Nutrition, Institut d'Investigacions Biomèdiques August Pi Suñer, CIBEROBN, Hospital Clínic Barcelona, 08036 Barcelona, Spain.ORCID 0000-0002-2217-8905
Manel Mata-CasesDAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.ORCID 0000-0003-3693-3622
Albert GodayDepartment of Endocrinology & Nutrition, Hospital del Mar, 08003 Barcelona, Spain.
Jordi RealDAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.
Angel RodriguezDepartment of Clinical Research, Lilly, S.A., 28108 Madrid, Spain.ORCID 0000-0001-8721-9539
Bogdan VlachoDAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.ORCID 0000-0003-3768-8112
Dídac MauricioDAP-Cat Group, Unitat de Suport a la Recerca Barcelona, Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), 08007 Barcelona, Spain.ORCID 0000-0002-2868-0250
Instituto de Salud Carlos III · ESCentro de Investigación Biomédica en Red · ESEli Lilly (Spain) · ESHospital General de Granollers · ESInstitut Universitari d'Investigació en Atenció Primària Jordi Gol · ESUniversitat Autònoma de Barcelona · ESUniversitat de Vic - Universitat Central de Catalunya · ES

Funding

Lilly S.A. Spain NA
6 · The paper itself

Abstract

backgroundThis study aims to evaluate the clinical characteristics, complications, degree of glycemic control, and cardiovascular risk factor control in patients with type 1 diabetes in Catalonia (Northwest of Spain).

methodsCross-sectional study using a database including clinical, laboratory, and treatment data. Patients with an ICD10 diagnosis of type 1 diabetes were included, excluding those treated with glucose-lowering agents other than insulin, or treated only with basal insulin two years after diagnosis.

results15,008 patients were analysed. Median IQR age was 42 (31-53) years, diabetes duration 11.8 (6.8-16.0) years, 56.5% men. Median (IQR) HbA1c was 7.9% (7.1-8.8). Microvascular complications were present in 24.4% of patients, 43.6% in those with a diabetes duration >19 years. In presence of known cardiovascular disease 69.3% of patients showed an LDL-C concentration >70 mg/dL, 37% had a systolic blood pressure >135 mmHg and 22.4% were smokers.

conclusionsThis study provides a reliable snapshot about the clinical situation of a large population of patients with T1D in Catalonia, which is similar to that of other western areas. The lack of adequate control of cardiovascular risk factors in a significant proportion of patients with cardiovascular disease deserves a more detailed analysis and urges the need for improvement strategies.

Indexed as

cardiovascular risk factorscomplicationsglucose controltype-1 diabetes

Identifiers

PMID33917523
PMCPMC8038775
OpenAlexW3145898000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.